A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial). (Q51334864)
Jump to navigation
Jump to search
scientific article published on 30 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial). |
scientific article published on 30 August 2013 |
Statements
A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial). (English)
1 reference
Judith Johnson
1 reference
Kevin C Maki
1 reference
David G Orloff
1 reference
Stephen J Nicholls
1 reference
Richard L Dunbar
1 reference
Eli M Roth
1 reference
Danielle Curcio
1 reference
Douglas Kling
1 reference
Michael H Davidson
1 reference
30 August 2013
1 reference
35
1 reference
9
1 reference
1400-11.e1-3
1 reference